GlassScriptPhysician profile
Alan Oshinsky
NPI 1205825890
$224.90
in general payments reported to CMS, 2019-2025
6 companies · $19.87 in 2025
The $19.87 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.82 · 2021: $26.49 · 2022: $20.01 · 2024: $62.71 · 2025: $19.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $82.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $82.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $102.33 | 2019-2024 | |
| Acclarent, INC | $39.01 | 2019 | |
| Dexcom, INC. | $24.81 | 2024 | Dexcom G6 Transmitter |
| Abbott Laboratories | $20.00 | 2019 | |
| Merck Sharp & Dohme LLC | $19.87 | 2025 | Keytruda |
| Corcept Therapeutics | $18.88 | 2024 | Korlym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Oshinsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.